More Australians now eligible for free shingles vaccination

22 September 2024 - The Albanese Government is expanding one of the most comprehensive and widely available shingles vaccination programs ...

Read more →

The impact of generic entry of pharmaceuticals in Australia

20 September 2024 - In this article, we estimate the initial and temporal impacts of generic entry on benchmark drug prices ...

Read more →

Program to protect SA newborns from RSV

17 September 2024 - South Australia will protect newborn babies from the impacts of respiratory syncytial virus for the winter ...

Read more →

Understanding modelled economic evaluations: a reader's guide for clinicians

26 August 2024 - Economic evaluations have a long history in health care. Full economic evaluations aim to inform decision making ...

Read more →

New medicines could be PBS listed in just four weeks under a proposal the health minister calls 'visionary'

11 September 2024 - Have you ever had to wait for an important and expensive medicine to be subsidised? ...

Read more →

HTA review outlines First Nations, pediatric reform and quick, cheap medicine

10 September 2024 - A Government review of Australia’s systems for accessing medicine has said it could slash waiting times ...

Read more →

Final reports of the HTA Policy and Methods Review and Enhanced Consumer Engagement Process

10 September 2024 - The reports of the HTA Review and the Enhanced Consumer Engagement Process have been published. ...

Read more →

New and expanded PBS listings for Fabry disease and kidney cancer

9 September 2024 - Australians with Fabry disease, a rare genetic condition, and people with kidney cancer now have access ...

Read more →

Agenda for the November 2024 PBAC meeting (version 4)

6 September 2024 - Version 4 of the agenda for the November 2024 PBAC meeting is now available. ...

Read more →

Australians save over half a billion dollars on cheaper medicines

1 September 2024 - Thanks to the Albanese Labor Government Australians have saved over half a billion dollars ($525 million) ...

Read more →

Cabometyx (cabozantinib) now available for eligible patients with non-clear cell renal cell carcinoma via the PBS

1 September 2024 - Cabometyx (cabozantinib), a once daily oral medication, is now available on the PBS for eligible patients with ...

Read more →

Schedule of Pharmaceutical Benefits - 1 September 2024

The September 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Public Summary Documents – May 2024 PBAC meeting

30 August 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2024 PBAC ...

Read more →

Agenda for the September 2024 PBAC intracycle meeting

30 August 2024 - The agenda for the September 2024 PBAC intracycle meeting is now available. ...

Read more →

Life prolonging breast cancer drug receives expanded access on the PBS

28 August 2024 - Australians diagnosed with a type of metastatic breast cancer will now have access to a life ...

Read more →